We are a world-leading cancer research institute, a charity, and a member institution of the University of London. Public donations and clinical partnerships are helping us to make the discoveries ...

The Royal Marsden NHS Foundation Trust is a world-leading specialist cancer hospital. The Institute of Cancer Research works in close partnership with The Royal Marsden to take the results of our ...

The Adult Drug Development Unit (DDU) at The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust, comprises an internationally-leading group of >100 staff focused on early ...

The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Cotswold Road, Sutton, Surrey, UK. This course is organised by the Joint Department of Physics of The Royal Marsden NHS ...

The Audit & Risk Committee supervises internal and external audit processes in order to safeguard the integrity of the ICR's financial systems and ensure economy, efficiency and effectiveness in the ...

We are overseeing several new ventures that could, with the right partner, become new companies in areas from digital pathology and artificial intelligence (AI) to cancer vaccines, from harnessing ...

The Institute of Cancer Research, London, is the second-ranked academic research centre in the UK - according to the Times Higher Education league table of university research quality and impact ...

Clinical trials are the single best way to turn advances in science into patient benefits. The ICR has a vision that a suitable trial should be made available for every person with cancer who wants to ...

The Centre for Cancer Drug Discovery at The Institute of Cancer Research, London, is the largest academic cancer drug discovery and development group worldwide. Its research groups cover every aspect ...

We have made huge strides in research and treatment for children with cancer, improving their chances of survival. With your support today, we can discover kinder treatments and offer more children ...

Dates for September 2026 to be confirmed. An opportunity to broaden your understanding of the capabilities and potential of MRI guidance in radiotherapy planning and treatment verification. We invite ...

Established in 2013 as the Tumour Profiling Unit (TPU), and now rebranded as the ICR’s Genomics Facility, the Facility provides access to a range of cutting-edge techniques for genomic, transcriptomic ...